Hearst Sustainability logo

Hearst Ventures

Hearst Ventures invests across the globe in early-stage technology businesses in sectors adjacent to Hearst’s core business ethos of integrity and innovation.

Improving health outcomes

The Hearst Health prize aims to identify at-risk patients earlier for timely intervention, enhancing access and availability of care for more effective treatment.

Hearst Ventures has invested over $1 billion

Established in 1995, Hearst Ventures has invested over
$1 billion in global startups. Ventures’ trajectory has mirrored the evolution of Hearst and its diverse portfolio of companies, from a focus on consumer media to diversified information
and B2B services. Ventures invested in early e-readers, ride sharing and circular economy platforms, as well as more efficient prescription management systems.

Ebook reader on a table

E Ink: First-Gen Digital Books 

E Ink, the technology that powered the first mass-adopted e-reader the Kindle, revolutionized the way people consume books, news and entertainment. In 2000, Hearst Ventures was one of the first to 
invest in this technology, recognizing the importance of staying in-step
with the rapid evolution of consumer media and reduction of paper printing. 

E-Ink
Zzer
ZZER warehouse

Share2/ZZER

Founded in 2015, ZZER is a first-of-its-kind online and in-person marketplace for luxury consignment in China. The business model focuses on an asset-light consignment model, helping sellers recycle over 1 million second-hand items and recoup their investments in luxury. ZZER itself is cognizant of its own footprint, investing in using recyclable materials in more than half of its packaging.

RXLightning
Doctor holding tablet

RXLightning: Medication Access and Affordability 

RXLightning is a platform founded to make specialty medications more affordable and accessible. The goal is to make enrollment, an often complicated process for life-altering therapies, a single, automated and seamless process. In 2024, it entered a partnership with KnippeRX to create a co-branded and integrated web portal that allows providers to enroll patients in the
FDA Patient Assistance Program. This approach reduces wait times to receive critical medications.